Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

Cited by (1,001)

Items 101–200 of 1,001

1. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine
   Prakash Priyadarshi Praharaj, Sujit K. Bhutia, Sunitha Nagrath, Rhonda Lynn Bitting, Gagan Deep · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
2. Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
   Xie, Feihu, Sun, Lejia, Pang, Yuan, Xu, Gang, Jin, Bao, Xu, Haifeng, Lu, Xin, Xu, Yiyao, Du, Shunda, Wang, Yanan et al. · 2021 · Biomaterials
3. Organoids in gastrointestinal diseases: From experimental models to clinical translation
   Günther, Claudia, Winner, Beate, Neurath, Markus F, Stappenbeck, Thaddeus S · 2022 · Gut
4. Large‐Scale Production of LGR5‐Positive Bipotential Human Liver Stem Cells
   Schneeberger, Kerstin, Sánchez‐Romero, Natalia, Ye, Shicheng, van Steenbeek, Frank G., Oosterhoff, Loes A., Pla Palacin, Iris, Chen, Chen, van Wolferen, Monique E., van Tienderen, Gilles, Lieshout, Ruby et al. · 2020 · Hepatology
5. High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39 + CD8 + T cells
   Ting Liu, Jizhou Tan, Minhao Wu, Wenzhe Fan, Jialiang Wei, Bowen Zhu, Jian Ming Guo, Shutong Wang, Penghui Zhou, Hui Zhang et al. · 2020 · Gut
6. Modeling Human Digestive Diseases With CRISPR-Cas9–Modified Organoids
   Masayuki Fujii, Hans C. Clevers, Toshiro Sato · 2018 · Gastroenterology
7. Organoid based personalized medicine: from bench to bedside
   Yaqi Li, Peiyuan Tang, Sanjun Cai, Junjie Peng, Guoqiang Hua · 2020 · Cell Regeneration
8. Patient-derived organoid (PDO) platforms to facilitate clinical decision making
   Lisa Liu, Lei Yu, Zhichao Li, Wujiao Li, Weiren Huang · 2021 · Journal of Translational Medicine
9. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology
   Shuyi Ji, Feng Li, Zile Fu, Gaohua Wu, Yingcheng Charles Wu, Youpei Lin, Dayun Lu, Yuanli Song, Peng Cui, Zijian Yang et al. · 2023 · Science Translational Medicine
10. Innovations, challenges, and minimal information for standardization of humanized mice
    Renata Stripecke, Christian Münz, Jan Jacob Schuringa, Karl‐Dimiter Bissig, Brian W. Soper, Terrence Meeham, Li‐Chin Yao, James P. Di Santo, Michael A. Brehm, Estefanía Rodríguez et al. · 2020 · EMBO Molecular Medicine
11. Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
    Zhichao Li, Youhui Qian, Wujiao Li, Lisa Liu, Lei Yu, Xia Liu, Guodong Wu, Youyu Wang, Weibin Luo, Fuyuan Fang et al. · 2020 · iScience
12. Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
    Sanae El Harane, Bochra Zidi, Nadia El Harane, Karl‐Heinz Krause, Thomas Matthes, Olivier Preynat‐Seauve · 2023 · Cells
13. Donafenib and GSK‐J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression
    Chenyang Zheng, Bo Zhang, Yunyun Li, Kejia Liu, Wei Wei, Shuhang Liang, Hongrui Guo, Kun Ma, Yao Liu, Jiabei Wang et al. · 2023 · Advanced Science
14. Single‐Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids
    Yan Zhao, Zhixuan Li, Yanjing Zhu, Jing Fu, Xiaofang Zhao, Yani Zhang, Shan Wang, Jianmin Wu, Kaiting Wang, Rui Ting Wu et al. · 2021 · Advanced Science
15. Patient-Derived Cancer Organoids as Predictors of Treatment Response
    Maikel Verduin, Ann Hoeben, Dirk De Ruysscher, Marc Vooijs · 2021 · Frontiers in Oncology
16. Recent advances in organoid development and applications in disease modeling
    Sanchita Rauth, Saswati Karmakar, Surinder K. Batra, Moorthy Palanimuthu Ponnusamy · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
17. Human airway organoids and microplastic fibers: A new exposure model for emerging contaminants
    Anna Winkler, Alessandro Cherubini, Francesco Rusconi, Nadia Santo, Laura Madaschi, Clelia Pistoni, Giorgia Moschetti, Maria Lucia Sarnicola, Mariacristina Crosti, Lorenzo Rosso et al. · 2022 · Environment International
18. Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth
    Meng Li, Ling Wang, Yijin Wang, Shaoshi Zhang, Guoying Zhou, Ruby Lieshout, Buyun Ma, Jiaye Liu, Changbo Qu, Monique M. A. Verstegen et al. · 2020 · Cells
19. The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription
    Anliang Xia, Wenwen Yuan, Qiang Wang, Jianbo Xu, Yayun Gu, Liansheng Zhang, Chen Chen, Zhangding Wang, Di Wu, Qifeng He et al. · 2022 · Nature Cancer
20. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles
    Helen H N Yan, Hoi Cheong Siu, Siu Lun Ho, Sarah S K Yue, Yang Gao, Wai Yin Tsui, Dessy Chan, April Chan, Jason W.H. Wong, Alice H Y Man et al. · 2020 · Gut
21. Harnessing the predictive power of preclinical models for oncology drug development
    Honkala, Alexander, Malhotra, Sanjay V., Kummar, Shivaani, Junttila, Melissa R. · 2022 · Nature Reviews Drug Discovery
22. Cancer research using organoid technology
    Kretzschmar, Kai · 2021 · Journal of Molecular Medicine
23. Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses
    Farin, Henner F., Mosa, Mohammed H., Ndreshkjana, Benardina, Grebbin, Britta M., Ritter, Birgit, Menche, Constantin, Kennel, Kilian B., Ziegler, Paul K., Szabó, Lili, Bollrath, Julia et al. · 2023 · Cancer Discovery
24. Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
    Chara Stavraka, Hannah L. Rush, Paul J. Ross · 2018 · Journal of Hepatocellular Carcinoma
25. Organoids are not organs: Sources of variation and misinformation in organoid biology
    Kim Bak Jensen, Melissa Helen Little · 2023 · Stem Cell Reports
26. Human biomimetic liver microphysiology systems in drug development and precision medicine
    Gough, Albert, Soto-Gutierrez, Alejandro, Vernetti, Lawrence, Ebrahimkhani, Mo R., Stern, Andrew M., Taylor, D. Lansing · 2021 · Nature Reviews Gastroenterology & Hepatology
27. The drug-induced phenotypic landscape of colorectal cancer organoids
    Johannes Betge, Niklas Rindtorff, Jan Sauer, Benedikt Rauscher, Clara Dingert, Haristi Gaitantzi, Frank Herweck, Kauthar Srour-Mhanna, Thilo Miersch, Erica Valentini et al. · 2022 · Nature Communications
28. Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy
    Meghan T. Logun, Xin Wang, Yusha Y. Sun, Stephen Joseph Bagley, Nannan Li, Arati Suvas Desai, Daniel Y. Zhang, MacLean P. Nasrallah, Emily Ling-Lin Pai, Bike Su Oner et al. · 2024 · Cell stem cell
29. The role of molecular enrichment on future therapies in hepatocellular carcinoma
    Jean‐Charles Nault, Peter R. Galle, Jens Uwe Marquardt · 2018 · Journal of Hepatology
30. The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity
    Fan Zou, Jizhou Tan, Ting Liu, Bingfeng Liu, Ya‐Ping Tang, Hui Zhang, Jiaping Li · 2021 · Molecular Therapy
31. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer–stromal interaction and metastasis
    Zilong Yan, Kenoki Ohuchida, Shuang Fei, Biao Zheng, Weiyu Guan, Haimin Feng, Shin Kibe, Yohei Ando, Kazuhiro Koikawa, Toshiya Abe et al. · 2019 · Journal of Experimental & Clinical Cancer Research
32. Functional precision oncology using patient-derived assays: bridging genotype and phenotype
    Allard W. J. van Renterghem, Joris van de Haar, Emile E. Voest · 2023 · Nature Reviews Clinical Oncology
33. 3D and organoid culture in research: physiology, hereditary genetic diseases and cancer
    Suarez-Martinez, Elisa, Suazo-Sanchez, Irene, Celis-Romero, Manuel, Carnero, Amancio · 2022 · Cell & Bioscience
34. Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells <i>in vitro</i>
    Yu, Lei, Li, Zhichao, Mei, Hongbin, Li, Wujiao, Chen, Dong, Liu, Lisa, Zhang, Zhongfu, Sun, Yangyang, Song, Fei, Chen, Wei et al. · 2021 · Clinical &amp; Translational Immunology
35. Patient‐derived renal cell carcinoma organoids for personalized cancer therapy
    Zhichao Li, Haibo Xu, Lei Yu, Jia Wang, Qian Meng, Hongbing Mei, Zhiming Cai, Wei Chen, Weiren Huang · 2022 · Clinical and Translational Medicine
36. Activation and antitumor immunity of CD8 + T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid
    Ying Liu, Feng Wang, Dongxue Peng, Dan Zhang, Luping Liu, Jun Wei, Jian Yuan, Luyao Zhao, Huimin Jiang, Tingting Zhang et al. · 2024 · Science Translational Medicine
37. Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids
    Siqi Wang, Yang Wang, Xiaodong Xun, Changkun Zhang, Xiang Xiao, Qian Cheng, Shihua Hu, Zhao Li, Jiye Zhu · 2020 · Journal of Experimental & Clinical Cancer Research
38. Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options
    Andreas Koulouris, Christos Tsagkaris, Vasiliki Spyrou, Eleni V. Pappa, Aikaterini Troullinou, Michail Nikolaou · 2021 · Journal of Hepatocellular Carcinoma
39. Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells
    Guoying Zhou, Ruby Lieshout, Gilles S. van Tienderen, Valeska de Ruiter, Martin E. van Royen, Patrick P.C. Boor, Luc Magré, Jyaysi Desai, Kübra Köten, Yik Y. Kan et al. · 2022 · British Journal of Cancer
40. Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data
    Ke Liu, Patrick A. Newbury, Benjamin Scott Glicksberg, Billy Zeng, Shreya Paithankar, Eran R. Andrechek, Bin Chen · 2019 · Nature Communications
41. Image-based high-content screening in drug discovery
    Sean Lin, Kenji Schorpp, Ina Rothenaigner, Kamyar Hadian · 2020 · Drug Discovery Today
42. Pluripotent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration
    Antonietta Messina, Eléanor Luce, Marwa Hussein, Anne Dubart‐Kupperschmitt · 2020 · Cells
43. Liver organoid as a 3D in vitro model for drug validation and toxicity assessment
    Anastasia Brooks, Xiaowen Liang, Yonglong Zhang, Chun‐Xia Zhao, Michael Stephen Roberts, Haolu Wang, Lei Zhang, Dorothy H. Crawford · 2021 · Pharmacological Research
44. Anticancer drug discovery using multicellular tumor spheroid models
    Michele Zanoni, Sara Pignatta, Chiara Arienti, Massimiliano Bonafè, Anna Tesei · 2019 · Expert Opinion on Drug Discovery
45. Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine
    Xi Chen, Yu Shrike Zhang, Xinping Zhang, Changsheng Liu · 2020 · Bioactive Materials
46. An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity
    Zhou, Zhuolong, Van der Jeught, Kevin, Fang, Yuanzhang, Yu, Tao, Li, Yujing, Ao, Zheng, Liu, Sheng, Zhang, Lu, Yang, Yang, Eyvani, Haniyeh et al. · 2021 · Nature Biomedical Engineering
47. Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
    Xiang, Dongxi, He, Aina, Zhou, Rong, Wang, Yonggang, Xiao, Xiuying, Gong, Ting, Kang, Wenyan, Lin, Xiaolin, Wang, Xiaochen, PDO-based DST Consortium11 et al. · 2024 · Theranostics
48. Modeling Cell Communication in Cancer With Organoids: Making the Complex Simple
    Elena Fiorini, Lisa Veghini, Vincenzo Corbo · 2020 · Frontiers in Cell and Developmental Biology
49. A pan-cancer organoid platform for precision medicine
    Larsen, Brian M., Kannan, Madhavi, Langer, Lee F., Leibowitz, Benjamin D., Bentaieb, Aicha, Cancino, Andrea, Dolgalev, Igor, Drummond, Bridgette E., Dry, Jonathan R., Ho, Chi-Sing et al. · 2021 · Cell Reports
50. Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy
    Else Driehuis, Sacha Spelier, Irati Beltrán Hernández, Remco de Bree, Stefan M. Willems, Hans C. Clevers, Sabrina Oliveira · 2019 · Journal of Clinical Medicine
51. Micro‐Engineered Organoid‐on‐a‐Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients
    Zhengyu Zou, Zhun Lin, Chenglin Wu, Jizhou Tan, Jie Zhang, Yanwen Peng, Kunsong Zhang, Jiaping Li, Minhao Wu, Yuanqing Zhang · 2023 · Advanced Science
52. Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
    Eliane Klein, Ann‐Christin Hau, Anaïs Oudin, Anna Golebiewska, Simone P. Niclou · 2020 · Frontiers in Oncology
53. Organoids in image-based phenotypic chemical screens
    Lukonin, Ilya, Zinner, Marietta, Liberali, Prisca · 2021 · Experimental &amp; Molecular Medicine
54. Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models
    Somshuvra Bhattacharya, Kristin Calar, Pilar de la Puente · 2020 · Journal of Experimental & Clinical Cancer Research
55. Organoids: a novel modality in disease modeling
    Zahra Heydari, Farideh Moeinvaziri, Tarun Agarwal, Paria Pooyan, Anastasia I. Shpichka, Tapas K. Maiti, Peter S. Timashev, Hossein Baharvand, Massoud Vosough · 2021 · Bio-Design and Manufacturing
56. Patient-derived organoids in translational oncology and drug screening
    Yang, Ruixin, Yu, Yingyan · 2023 · Cancer Letters
57. Assembly of functionalized silk together with cells to obtain proliferative 3D cultures integrated in a network of ECM-like microfibers
    Ulrika Johansson, Mona Widhe, Nancy Dekki Shalaly, Irene Linares Arregui, Linnea Nilebäck, Christos Panagiotis Tasiopoulos, Carolina Åstrand, Per‐Olof Berggren, Christian T. Gasser, My Hedhammar · 2019 · Scientific Reports
58. The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
    Joseph H. Azar, Hisham F. Bahmad, Darine Daher, Maya M. Moubarak, Ola Hadadeh, Alissar Monzer, Samar Al Bitar, Mohamed Jamal, Mohamed Al‐Sayegh, Wassim G. Abou-Kheir · 2021 · International Journal of Molecular Sciences
59. Long-term live imaging and multiscale analysis identify heterogeneity and core principles of epithelial organoid morphogenesis
    Lotta Hof, Till Moreth, Michael Koch, Tim Liebisch, Marina Kurtz, Julia Tarnick, Susanna M. Lissek, Monique M. A. Verstegen, Luc J. W. van der Laan, Meritxell Huch et al. · 2021 · BMC Biology
60. Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma
    Jiaomeng Pan, Mao Zhang, Liangqing Dong, Shuyi Ji, Juan Zhang, Shu Jie Zhang, Youpei Lin, Xiaoying Wang, Zhen‐Bin Ding, Shuang–Jian Qiu et al. · 2022 · Autophagy
61. Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications
    Min‐Ying Su, Tao Pan, Qiu-Zhen Chen, Weiwei Zhou, Yi Gong, Gang Xu, Huan-Yu Yan, Si Li, Qiao-Zhen Shi, Ya Zhang et al. · 2022 · Military Medical Research
62. Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma
    Qiangnu Zhang, Lingfeng Xiong, Teng Wei, Quan Liu, Lesen Yan, Jiaojuan Chen, Lu Dai, Lulin Shi, Wenjian Zhang, Jilin Yang et al. · 2023 · Oncogene
63. Patient-derived organoids: a promising model for personalized cancer treatment
    Huayu Yang, Lejia Sun, Meixi Liu, Yilei Mao · 2018 · Gastroenterology report
64. Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research
    Fahriye Düzağaç, Gloria Saorin, Lorenzo Memeo, Vincenzo Canzonieri, Flavio Rizzolio · 2021 · Cancers
65. iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine
    Olgasi, Cristina, Cucci, Alessia, Follenzi, Antonia · 2020 · International Journal of Molecular Sciences
66. Evolution of the Experimental Models of Cholangiocarcinoma
    Annamaria Massa, Chiara Varamo, Francesca Vita, Simona Tavolari, Caterina Peraldo Neia, Giovanni Brandi, Alessandro Rizzo, Giuliana Cavalloni, Massimo Aglietta · 2020 · Cancers
67. Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine
    Qigu Yao, Sheng Cheng, Qiaoling Pan, Jiong Yu, Guoqiang Cao, Lanjuan Li, Hongcui Cao · 2024 · MedComm
68. Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
    Bernarda Majc, Metka Novak, Nataša Kopitar‐Jerala, Anahid Jewett, Barbara Breznik · 2021 · Cells
69. Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
    Malia Alexandra Foo, Ming You, Shing Leng Chan, Gautam Sethi, Glenn Kunnath Bonney, Wei Peng Yong, Edward Kai‐Hua Chow, Eliza Li Shan Fong, Lingzhi Wang, Boon-Cher Goh · 2022 · Biomarker Research
70. 3D cancer models: One step closer to in vitro human studies
    Nicoletta Manduca, Ester Maccafeo, Ruggero D. Maria, Antonella Sistigu, Martina Musella · 2023 · Frontiers in Immunology
71. Engineering Precision Medicine
    Wujin Sun, Junmin Lee, Shiming Zhang, Cole Benyshek, Mehmet R. Dokmeci, Ali Khademhosseini · 2018 · Advanced Science
72. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
    Shanqiang Qu, Rongyang Xu, Guozhong Yi, Zhiyong Li, Huayang Zhang, Songtao Qi, Guanglong Huang · 2024 · Molecular Biomedicine
73. Three-dimensional cell culture: from evolution to revolution
    Sharmin Alhaque, Michael Themis, Hassan Rashidi · 2018 · Philosophical Transactions of the Royal Society B Biological Sciences
74. Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity
    Stefano Caruso, Daniel R. O’Brien, Sean Patrick Cleary, Lewis Rowland Roberts, Jessica Zucman‐Rossi · 2020 · Hepatology
75. Bioprinting of in vitro tumor models for personalized cancer treatment: a review
    Shuangshuang Mao, Yuan Pang, Tiankun Liu, Yongchun Shao, Jianyu He, Huayu Yang, Yilei Mao, Wei Sun · 2020 · Biofabrication
76. Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment
    Elena Maria Tosca, Davide Ronchi, Daniele Facciolo, Paolo Magni · 2023 · Biomedicines
77. High-throughput microfluidic systems accelerated by artificial intelligence for biomedical applications
    Jianhua Zhou, Jianpei Dong, Hongwei Hou, Lü Huang, Jinghong Li · 2024 · Lab on a Chip
78. Obesity, sleep apnea, and cancer
    Isaac Almendros, Miguel Ángel Martínez‐García, Ramón Farré, David Gozal · 2020 · International Journal of Obesity
79. Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids
    Marius F. Harter, Timothy Recaldin, Régine Gérard, Blandine Avignon, Yannik Bollen, Cinzia Esposito, Karolina Guja-Jarosz, Kristina Kromer, Adrian M. Filip, Julien Aubert et al. · 2023 · Nature Biomedical Engineering
80. Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
    Daisong Wang, Rémi Villenave, Nadine Stokar‐Regenscheit, Hans C. Clevers · 2025 · Nature Reviews Drug Discovery
81. Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH
    McCarron, Sarah, Bathon, Brooke, Conlon, Donna M., Abbey, Deepti, Rader, Daniel J., Gawronski, Katerina, Brown, Christopher D., Olthoff, Kim M., Shaked, Abraham, Raabe, Tobias D. · 2021 · Hepatology
82. ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma
    Xiaofang Zhao, Wenhao Qin, Youhai Jiang, Zhishi Yang, Bo Yuan, Rongyang Dai, Hao Shen, Yao Chen, Jing Fu, Hongyang Wang · 2020 · npj Precision Oncology
83. Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments
    Qian Wang, Fangwei Yuan, Xianglin Zuo, Ming Li · 2025 · Cell Death Discovery
84. Advanced human developmental toxicity and teratogenicity assessment using human organoid models
    Li, Minghui, Gong, Jing, Gao, Lixiong, Zou, Ting, Kang, Jiahui, Xu, Haiwei · 2022 · Ecotoxicology and Environmental Safety
85. Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer
    Jialong Zhu, Linlin Ji, Yitian Chen, Huiyu Li, Mengxi Huang, Zhe Dai, Jing Wang, Dan Xiang, Gongbo Fu, Zengjie Lei et al. · 2023 · Cell Death Discovery
86. Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems
    Silva-Pedrosa, Rita, Salgado, António José, Ferreira, Pedro Eduardo · 2023 · Cells
87. A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS
    Xiaohua Duan, Tuo Zhang, Lingling Feng, Neranjan de Silva, Benjamin C. Greenspun, Xing Wang, Jenna E. Moyer, M. Laura Martin, Rohit Chandwani, Olivier Elemento et al. · 2023 · Cell stem cell
88. LGR5 marks targetable tumor-initiating cells in mouse liver cancer
    Wanlu Cao, Meng Li, Jiaye Liu, Shaoshi Zhang, Lisanne Noordam, Monique M. A. Verstegen, Ling Wang, Buyun Ma, Shan Li, Wenshi Wang et al. · 2020 · Nature Communications
89. Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
    Jungeun Lim, Hanna Ching, Jeong‐Kee Yoon, Noo Li Jeon, YongTae Kim · 2021 · Nano Convergence
90. Untangling the web of intratumour heterogeneity
    Zheqi Li, Marco Seehawer, Kornélia Polyák · 2022 · Nature Cell Biology
91. Role of Patient-Derived Models of Cancer in Translational Oncology
    K. Idrisova, Hans‐Uwe Simon, Marina O. Gomzikova · 2022 · Cancers
92. Animal models of cholangiocarcinoma
    Emilien J. Loeuillard, Samantha R. Fischbach, Gregory James Gores, Sumera Irie Ilyas · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
93. Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate
    Fan-En Kong, Guangmeng Li, Yun-Qiang Tang, Shaoyan Xi, Jane Ho Chun Loong, Meimei Li, Haolong Li, Wei Cheng, Wenjie Zhu, Jia-Qiang Mo et al. · 2021 · Science Translational Medicine
94. Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
    Christian Hirt, Tijmen H. Booij, Linda Grob, Patrik Simmler, Nora C. Toussaint, David Keller, Doreen Taube, Vanessa Ludwig, Alexander Goryachkin, Chantal Pauli et al. · 2022 · Cell Genomics
95. Construction of tumor organoids and their application to cancer research and therapy
    Jiajing Lv, Xuan Du, Miaomiao Wang, Jiacan Su, Yan Wei, Can Xu · 2024 · Theranostics
96. Phosphorylation regulates cullin-based ubiquitination in tumorigenesis
    Yifan Chen, Xuejing Shao, Ji Cao, Hong Zhu, Bo Yang, Qiaojun He, Meidan Ying · 2020 · Acta Pharmaceutica Sinica B
97. Recent methods of droplet microfluidics and their applications in spheroids and organoids
    Yihe Wang, Mengqi Liu, Yu Zhang, Hong Liu, Lin Ge Han · 2023 · Lab on a Chip
98. Organoid models for translational pancreatic cancer research
    Hervé Tiriac, Dennis Plenker, Lindsey A. Baker, David Arthur Tuveson · 2019 · Current Opinion in Genetics & Development
99. Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications
    Vitor Rodrigues da Costa, Rodrigo Pinheiro Araldi, Hugo Vigerelli, Fernanda D’Ámelio, Thais Biude Mendes, Vivian Fonseca Gonzaga, Bruna de Oliveira Policiquio, Gabriel Avelar Colozza‐Gama, Cristiane Wenceslau Valverde, Irina Kerkis · 2021 · Cells
100. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
     Rocı́o I.R. Macı́as, Vincenzo Cardinale, Timothy James Kendall, Matias Antonio Avila, Maria Guido, Cédric Coulouarn, Chiara Braconi, Adam Enver Frampton, John A. Bridgewater, Diletta Overi et al. · 2022 · Gut